Chemoprevention of hormone receptor-negative breast cancer: new approaches needed

被引：0
|
作者：
Brown, P. H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(10)70758-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [1] Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed
    Uray, Ivan P.
    Brown, Powel H.
    CLINICAL CANCER PREVENTION, 2011, 188 : 147 - 162
  • [2] Translational approaches for the prevention of estrogen receptor-negative breast cancer
    Li, Yuxin
    Brown, Powel H.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2007, 16 (03) : 203 - 215
  • [3] Hormone receptor-negative breast cancer: a study of prognostic factors
    Soares, R.
    Shvets, Y.
    Faustino, I.
    Afonso, N.
    Sousa, S.
    Rodrigues, H.
    EJC SUPPLEMENTS, 2010, 8 (03): : 106 - 106
  • [4] Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
    Hoon, Siao-Nge
    Lau, Peter K. H.
    White, Alison M.
    Bulsara, Max K.
    Banks, Patricia D.
    Redfern, Andrew D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [5] Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer
    Schummer, Michel
    Thorpe, Jason
    Giraldez, Maria
    Bergan, Lindsay
    Tewari, Muneesh
    Urban, Nicole
    PLOS ONE, 2015, 10 (11):
  • [6] Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor-Negative Breast Cancer
    Shen, Yu
    Costantino, Joseph P.
    Qin, Jing
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (20) : 1448 - 1453
  • [7] Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80
    Weiss, Anna
    Noorbaksh, Abraham
    Tokin, Christopher
    Chang, David
    Blair, Sarah L.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (10) : 3274 - 3278
  • [8] Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80
    Anna Weiss
    Abraham Noorbaksh
    Christopher Tokin
    David Chang
    Sarah L. Blair
    Annals of Surgical Oncology, 2013, 20 : 3274 - 3278
  • [9] Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
    Green, M. D.
    Francis, P. A.
    Gebski, V.
    Harvey, V.
    Karapetis, C.
    Chan, A.
    Snyder, R.
    Fong, A.
    Basser, R.
    Forbes, J. F.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1813 - 1817
  • [10] Estrogen Receptor Positive and Progesterone Receptor-negative Breast Cancer: The Role of Hormone Therapy
    Habibi, Mehran
    Canner, Joseph
    Dembinski, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S467 - S467
12345